Medications for Retinopathy of Prematurity
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Retinopathy of Prematurity.
Found 1 Approved Drug for Retinopathy of Prematurity
Aflibercept
Brand Names
EYDENZELT boav, Eylea, Zaltrap, Pavblu
Aflibercept
Brand Names
EYDENZELT boav, Eylea, Zaltrap, Pavblu
Form: Injection, Solution
Method of administration: Intravenous, Intravitreal
FDA approval date: November 21, 2011
Classification: Vascular Endothelial Growth Factor Inhibitor
EYDENZELT is indicated for the treatment of: EYDENZELT is a vascular endothelial growth factor (VEGF) inhibitor indicated for the treatment of patients with: Neovascular (Wet) Age-Related Macular Degeneration (AMD).
Showing 1-1 of 1
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances